Alzheimer's Association Creates Training, Certification Program
The Alzheimer's Association recently launched a new training program with certification exam to advance the de.... Read More
On June 7, the Food & Drug Administration approved Aduhelm (aducanumab) to treat Alzheimer's patients, making it the first new drug approval for a disease impacting more t.... Read More
Nashville-based data analytics company IQuity recently received a $320,000 grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH). T.... Read More
Patients, Researchers, Caregivers All Score Wins
In March, President Donald Trump signed a massive $1.3 trillion omnibus spending bill into law to fund the federal government..... Read More
In late December, Vanderbilt University scientists received the green light from the U.S. Food and Drug Administration (FDA) to proceed to clinical testing in humans for an in.... Read More
The landmark Alzheimer's Disease Neuroimaging Initiative (ADNI) began in October 2004 with a goal of finding more sensitive and accurate methods to detect Alzheimer's disease.... Read More